Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs. It also provides outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder. In addition, the company provides mental health services; rehabilitation services comprising relapse prevention and social integration services, as well as vocational opportunities; acute services for patients at risk to themselves or others, as well as crisis intervention and treatment of behavioral emergencies; and long-term and non-acute care services for adults suffering from mental illness, addiction, learning disability, or brain injury. Further, it provides education and children's services for children and young people with special educational needs; adult and elderly care services; and care first services for employees. As of December 31, 2017, the company operated a network of 582 behavioral healthcare facilities with approximately 17,800 beds in the United States, the United Kingdom, and Puerto Rico. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Industry, Sector and Symbol
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryHealth Care Facilities
SectorMedical
Phone615-861-6000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.84 billion
Profitability
Miscellaneous
Employees40,600
OptionableOptionable
Acadia Healthcare (NASDAQ:ACHC) Frequently Asked Questions
What is Acadia Healthcare's stock symbol?
Acadia Healthcare trades on the NASDAQ under the ticker symbol "ACHC."
How were Acadia Healthcare's earnings last quarter?
Acadia Healthcare Company Inc (NASDAQ:ACHC) issued its quarterly earnings data on Monday, July, 30th. The company reported $0.70 earnings per share for the quarter, hitting analysts' consensus estimates of $0.70. The firm earned $765.70 million during the quarter, compared to analysts' expectations of $767.93 million. Acadia Healthcare had a return on equity of 7.71% and a net margin of 7.43%. The firm's quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.66 EPS. View Acadia Healthcare's Earnings History.
When is Acadia Healthcare's next earnings date?
How can I listen to Acadia Healthcare's earnings call?
Acadia Healthcare will be holding an earnings conference call on Friday, March 1st at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.
What price target have analysts set for ACHC?
11 Wall Street analysts have issued 12-month target prices for Acadia Healthcare's stock. Their forecasts range from $27.00 to $45.00. On average, they expect Acadia Healthcare's share price to reach $39.60 in the next twelve months. This suggests a possible upside of 41.0% from the stock's current price. View Analyst Price Targets for Acadia Healthcare.
What is the consensus analysts' recommendation for Acadia Healthcare?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acadia Healthcare in the last year. There are currently 8 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Acadia Healthcare.
What are Wall Street analysts saying about Acadia Healthcare stock?
Here are some recent quotes from research analysts about Acadia Healthcare stock:
- 1. According to Zacks Investment Research, "Acadia Healthcare has been able to grow its top line on the back of organic and inorganic growth initiatives. The company has been actively emphasizing on acquisitions for expedited growth. Moreover, it is well positioned to fund its new bed development. The company’s robust balance sheet also impresses. However, its long-term debt has increased consistently for the past many years, leading to an increase in interest expense. The company has been witnessing rising expenses since 2009 inducing margin contraction. Shares of the company have lost in a year's time, comparing unfavorably with the industry's gain in the same time frame. A Zacks Rank #2 and an earnings ESP of 0.00% leave us inconclusive of an earnings surprise as it reports its fourth-quarter earnings on February 28." (2/18/2019)
- 2. Cantor Fitzgerald analysts commented, "We rate ACHC Neutral primarily to reflect our view of the uncertainty associated with the recovery of its U.K. business, which accounts for 40% of the company’s revenue. $39 price target is based on comparable-company analysis and our DCF. The Disclosure Section may be found on pages 3 – 4.Valuation Our $39 price target reflects our reservations about the company’s ability to grow both organically and through acquisitions." (11/16/2018)
Has Acadia Healthcare been receiving favorable news coverage?
Press coverage about ACHC stock has trended neutral on Wednesday, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Acadia Healthcare earned a coverage optimism score of 0.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the company's share price in the immediate future.
Who are some of Acadia Healthcare's key competitors?
Some companies that are related to Acadia Healthcare include Cochlear (COH), Davita (DVA), DENTSPLY SIRONA (XRAY), Henry Schein (HSIC), Sarepta Therapeutics (SRPT), Aurora Cannabis (ACB), Genmab A/S (GNMSF), Bausch Health Companies (BHC), Alnylam Pharmaceuticals (ALNY), Qiagen (QGEN), H. Lundbeck A/S- (HLUYY), WILLIAM DEMANT/ADR (WILYY), Molina Healthcare (MOH), Ionis Pharmaceuticals (IONS) and Bio-Rad Laboratories (BIO).
Who are Acadia Healthcare's key executives?
Acadia Healthcare's management team includes the folowing people:
- Mr. William Brent Turner, Pres (Age 53)
- Mr. David M. Duckworth, CFO, Chief Accounting Officer & Controller (Age 39)
- Mr. Ronald Morgon Fincher, Chief Operating Officer (Age 66)
- Mr. Christopher L. Howard, Exec. VP, Gen. Counsel & Sec. (Age 52)
- Ms. Debra K. Osteen, CEO & Director (Age 63)
Who are Acadia Healthcare's major shareholders?
Acadia Healthcare's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.08%), Dimensional Fund Advisors LP (6.34%), Elliott Management Corp (3.68%), First Trust Advisors LP (1.52%), Bank of New York Mellon Corp (1.17%) and Rothschild & Co. Asset Management US Inc. (1.10%). Company insiders that own Acadia Healthcare stock include Brent Turner, Christopher L Howard, Joey A Jacobs, Randall P Goldberg, Reeve B Waud, Ronald Morgan Fincher, Scott Schwieger and William Grieco. View Institutional Ownership Trends for Acadia Healthcare.
Which major investors are selling Acadia Healthcare stock?
ACHC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Frontier Capital Management Co. LLC, Millennium Management LLC, Tekla Capital Management LLC, Oak Ridge Investments LLC, Bank of America Corp DE, Skyline Asset Management LP and American Assets Investment Management LLC. Company insiders that have sold Acadia Healthcare company stock in the last year include Randall P Goldberg and Reeve B Waud. View Insider Buying and Selling for Acadia Healthcare.
Which major investors are buying Acadia Healthcare stock?
ACHC stock was acquired by a variety of institutional investors in the last quarter, including Elliott Management Corp, Oregon Public Employees Retirement Fund, First Trust Advisors LP, Brandywine Global Investment Management LLC, Dimensional Fund Advisors LP, Prudential Financial Inc., Maso Capital Partners Ltd and Ontario Teachers Pension Plan Board. View Insider Buying and Selling for Acadia Healthcare.
How do I buy shares of Acadia Healthcare?
Shares of ACHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Acadia Healthcare's stock price today?
One share of ACHC stock can currently be purchased for approximately $28.09.
How big of a company is Acadia Healthcare?
Acadia Healthcare has a market capitalization of $2.48 billion and generates $2.84 billion in revenue each year. The company earns $199.83 million in net income (profit) each year or $2.30 on an earnings per share basis. Acadia Healthcare employs 40,600 workers across the globe.
What is Acadia Healthcare's official website?
How can I contact Acadia Healthcare?
Acadia Healthcare's mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The company can be reached via phone at 615-861-6000.
MarketBeat Community Rating for Acadia Healthcare (NASDAQ ACHC)
MarketBeat's community ratings are surveys of what our community members think about Acadia Healthcare and other stocks. Vote "Outperform" if you believe ACHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
